Skip to main content

Fan Yu

SEC CIK
0001668029
Latest filing
Aug 14, 2026

Holdings in Q1 2024

Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.

Institution overview
Positions
5
+1 vs. Q4 2023
Portfolio value
$72.5M
+$52.6M (+263.5%) vs. Q4 2023
Filed
May 15, 2024
SEC
Holdings of Fan Yu in Q1 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
PREPrenetics Global LtdCLASS A ORD1,252,438$55.0M75.8%+1,252,438NewHistory
SYRESpyre Therapeutics, Inc.COM737,000$16.4M22.7%+737,000NewHistory
SONXSonendo, Inc.COM22,503$498.4K0.7%+22,503NewHistory
SGMTSagimet Biosciences Inc.COM SER A57,190$310.0K0.4%00.0%UnchangedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK69,303$295.2K0.4%00.0%UnchangedHistory

Sold out since Q4 2023 (2)

Positions held at the end of Q4 2023 that are gone from this filing.

Positions of Fan Yu sold out since Q4 2023
SecurityClassShares in Q4 2023Value in Q4 2023% of portfolio in Q4 2023History
CRGXCARGO Therapeutics, Inc.COM822,171$19.0M95.4%History
CSTLCastle Biosciences IncCOM22,503$485.6K2.4%History